Metabolite details
Reactome pathways
- No Reactome pathways listed for this metabolite.
Observed in studies
- Biological effect of chronic mistranslation in mammalian cells
- Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
- Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Escherichia coli assays)
- Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
- Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Klebsiella pneumoniae assays)
- Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Streptococcus pyogenes assays)
- Metabolic Responses of a Model Green Microalga Euglena gracilis to Different Environmental Stresses
- Multiomics of tomato glandular trichomes reveals distinct features of central carbon metabolism supporting high productivity of specialized metabolites
- Gut microbiome drives individual memory variation in bumblebees
- Metabolic profilings of rat INS-1 β-cells under changing levels of essential amino acids
- Proteomic and metabolic changes in cancer cells after alternation of SHMT2 expressions
- Homeostasis of the biosynthetic E. coli metabolome
- Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors
- PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis.
- Integrated Proteomic and Metabolomic Analyses Show Differential Effects of Glucose Availability in Marine <i>Synechococcus</i> and <i>Prochlorococcus</i>.
- TGF-β uncouples glycolysis and inflammation in macrophages and controls the survival during sepsis
- L-leucine increases the sensitivity of drug-resistant Salmonella to sarafloxacin by stimulating central carbon metabolism and increasing intracellular reactive oxygen species level (LC-MS positive mode)
- L-leucine increases the sensitivity of drug-resistant Salmonella to sarafloxacin by stimulating central carbon metabolism and increasing intracellular reactive oxygen species level (LC-MS negative mode)
- Unexpected similarities between the Schizosaccharomyces and human blood metabolomes, and novel human metabolites (Blood fraction)
Observed in differential profiles
- rps2_wildtype_vs_rps2_A226Y
- Control_16.6_months_vs_Treatment_16.6_months
- RPMI_B36_vs_Pooled_Sera_B36
- G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
- G1_Klebsiella_pneumoniae_AJ218_RPMI_vs_G2_Klebsiella_pneumoniae_AJ218_Pooled_sera
- G1_RPMI_modified_Blood_M1T1_5448_vs_G2_Pooled_sera_Blood_M1T1_5448
- Control_vs_Paramycin
- Solanum_habrochaites_leaf_vs_glandular_trichome
- Hindgut_Control_vs_Lactobacillus_apis
- G1_Control_vs_G2_Arginine_Addition
- Control_No_Glycine_vs_SHMT2_Upregulated_No_Glycine
- Glu_BW25113_vs_Pyr_BW25113
- Wild_Type_vs_Gene_Knockout
- MCF-7_WT_vs_MCF-7_PKM2_KO
- SS120_Control_vs_SS120_5mM
- SS120_Control_vs_SS120_5mM
- Control_vs_TGF-beta_Treatment
- SAR-S_vs_SAR-R
- SAR-R_vs_SAR-S
- Human_Blood_vs_Human_Plasma
- Human_Blood_vs_Human_Plasma
- Human_Blood_vs_Human_Plasma